These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Transcriptional dysregulation during myeloid transformation in AML. Pabst T; Mueller BU Oncogene; 2007 Oct; 26(47):6829-37. PubMed ID: 17934489 [TBL] [Abstract][Full Text] [Related]
6. Capillary gel electrophoresis: a simple method for identification of mutations and polymorphisms in the CEBPA gene in patients with acute myeloid leukaemia. Juhl-Christensen C; Bomberg M; Melsvik D; Hokland P; Nyvold CG Eur J Haematol; 2008 Oct; 81(4):273-80. PubMed ID: 18616509 [TBL] [Abstract][Full Text] [Related]
7. CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. Fröhling S; Schlenk RF; Stolze I; Bihlmayr J; Benner A; Kreitmeier S; Tobis K; Döhner H; Döhner K J Clin Oncol; 2004 Feb; 22(4):624-33. PubMed ID: 14726504 [TBL] [Abstract][Full Text] [Related]
8. K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML). Carnicer MJ; Lasa A; Buschbeck M; Serrano E; Carricondo M; Brunet S; Aventin A; Sierra J; Di Croce L; Nomdedeu JF Ann Hematol; 2008 Oct; 87(10):819-27. PubMed ID: 18587575 [TBL] [Abstract][Full Text] [Related]
9. Activation of the unfolded protein response in human acute myeloid leukemia. Schardt JA; Mueller BU; Pabst T Methods Enzymol; 2011; 489():227-43. PubMed ID: 21266233 [TBL] [Abstract][Full Text] [Related]
10. PU.1 and CEBPA expression in acute myeloid leukemia. D'Alò F; Di Ruscio A; Guidi F; Fabiani E; Greco M; Rumi C; Hohaus S; Voso MT; Leone G Leuk Res; 2008 Sep; 32(9):1448-53. PubMed ID: 18308386 [TBL] [Abstract][Full Text] [Related]
11. Complexity of miR-223 regulation by CEBPA in human AML. Eyholzer M; Schmid S; Schardt JA; Haefliger S; Mueller BU; Pabst T Leuk Res; 2010 May; 34(5):672-6. PubMed ID: 20018373 [TBL] [Abstract][Full Text] [Related]
12. Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2. Snaddon J; Smith ML; Neat M; Cambal-Parrales M; Dixon-McIver A; Arch R; Amess JA; Rohatiner AZ; Lister TA; Fitzgibbon J Genes Chromosomes Cancer; 2003 May; 37(1):72-8. PubMed ID: 12661007 [TBL] [Abstract][Full Text] [Related]
13. CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma. Fuchs O; Provaznikova D; Kocova M; Kostecka A; Cvekova P; Neuwirtova R; Kobylka P; Cermak J; Brezinova J; Schwarz J; Markova J; Salaj P; Klamova H; Maaloufova J; Lemez P; Novakova L; Benesova K Blood Cells Mol Dis; 2008; 40(3):401-5. PubMed ID: 18182175 [TBL] [Abstract][Full Text] [Related]
14. [Roles of CEBPA mutation and expression abnormality in acute myeloid leukemia - review]. Wang LM; Xiao HW; Huang H Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1256-60. PubMed ID: 23114160 [TBL] [Abstract][Full Text] [Related]
15. Rapid and sensitive screening for CEBPA mutations in acute myeloid leukaemia. Benthaus T; Schneider F; Mellert G; Zellmeier E; Schneider S; Kakadia PM; Hiddemann W; Bohlander SK; Feuring-Buske M; Braess J; Spiekermann K; Dufour A Br J Haematol; 2008 Oct; 143(2):230-9. PubMed ID: 18752591 [TBL] [Abstract][Full Text] [Related]
16. Inactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid Leukemia. Seipel K; Marques MT; Bozzini MA; Meinken C; Mueller BU; Pabst T Clin Cancer Res; 2016 Feb; 22(3):746-56. PubMed ID: 26408402 [TBL] [Abstract][Full Text] [Related]
17. CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis. Awad MM; Aladle DA; Abousamra NK; Elghannam DM; Fawzy IM Hematology; 2013 Mar; 18(2):61-8. PubMed ID: 22990006 [TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling for improved dissection of acute leukemia: a recently identified immature myeloid/T-lymphoid subgroup as an example. Wouters BJ; Koss C; Delwel R Blood Cells Mol Dis; 2008; 40(3):395-400. PubMed ID: 18096415 [TBL] [Abstract][Full Text] [Related]
19. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells. Lin LI; Chen CY; Lin DT; Tsay W; Tang JL; Yeh YC; Shen HL; Su FH; Yao M; Huang SY; Tien HF Clin Cancer Res; 2005 Feb; 11(4):1372-9. PubMed ID: 15746035 [TBL] [Abstract][Full Text] [Related]